Literature DB >> 9107383

Potent inhibition of respiratory syncytial virus by polyoxometalates of several structural classes.

D L Barnard1, C L Hill, T Gage, J E Matheson, J H Huffman, R W Sidwell, M I Otto, R F Schinazi.   

Abstract

A series of polyoxometalates (POM) were synthesized and evaluated for anti-respiratory syncytial virus (RSV) activity. POM containing zirconium, tungsten, silicon, platinum, niobium or germanium of a variety of structural types have been evaluated. Sixteen of the compounds had very striking anti-RSV activity against a clinical isolate, Utah 89, with median effective concentration (EC50) values < or = 3 microM and selective indices > 80 as determined by viral cytopathic inhibition effect, neutral red uptake and virus yield reduction assays. The EC50 values for all three assays correlated very well (Pearson correlation coefficients > 0.90). POM containing sodium cations were totally inactive. Germanium-, niobium-, tin- and zirconium-containing compounds were found to be highly potent and selective. The antiviral activity was not cell line-dependent. The median cytotoxic concentration (IC50) values were generally greater than 100 microM. The compounds were also comparably active against a known laboratory RSV strain, A2, as well as other RSV strains. To detect any virus strain-specific inhibitory activity, seven POM were tested against other RSV strains; all were nearly equally inhibitory to the human virus strains, suggesting no strain specificity. Timing studies suggested that these compounds were most inhibitory during virus adsorption and penetration, although RSV was still significantly inhibited when the compound was added 3 h post-infection; which is considered well into the eclipse period. These data suggest that these potent, non-toxic compounds should be further studied as potential chemotherapeutic agents for treating RSV infections.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9107383     DOI: 10.1016/s0166-3542(96)01019-4

Source DB:  PubMed          Journal:  Antiviral Res        ISSN: 0166-3542            Impact factor:   5.970


  17 in total

1.  The ribavirin analog ICN 17261 demonstrates reduced toxicity and antiviral effects with retention of both immunomodulatory activity and reduction of hepatitis-induced serum alanine aminotransferase levels.

Authors:  R C Tam; K Ramasamy; J Bard; B Pai; C Lim; D R Averett
Journal:  Antimicrob Agents Chemother       Date:  2000-05       Impact factor: 5.191

Review 2.  Respiratory syncytial virus infection: immune response, immunopathogenesis, and treatment.

Authors:  J B Domachowske; H F Rosenberg
Journal:  Clin Microbiol Rev       Date:  1999-04       Impact factor: 26.132

3.  RhoA-derived peptide dimers share mechanistic properties with other polyanionic inhibitors of respiratory syncytial virus (RSV), including disruption of viral attachment and dependence on RSV G.

Authors:  Philip J Budge; Yeqiang Li; Judy A Beeler; Barney S Graham
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

4.  Marilones A-C, phthalides from the sponge-derived fungus Stachylidium sp.

Authors:  Celso Almeida; Stefan Kehraus; Miguel Prudêncio; Gabriele M König
Journal:  Beilstein J Org Chem       Date:  2011-12-05       Impact factor: 2.883

5.  Is the anti-psychotic, 10-(3-(dimethylamino)propyl)phenothiazine (promazine), a potential drug with which to treat SARS infections? Lack of efficacy of promazine on SARS-CoV replication in a mouse model.

Authors:  Dale L Barnard; Craig W Day; Kevin Bailey; Matthew Heiner; Robert Montgomery; Larry Lauridsen; Kie-Hoon Jung; Joseph K-K Li; Paul K S Chan; Robert W Sidwell
Journal:  Antiviral Res       Date:  2008-01-11       Impact factor: 5.970

6.  A Novel Application of Ti-Substituted Polyoxometalates: Anti-Inflammatory Activity in OVA-Induced Asthma Murine Model.

Authors:  Dong Li; Xiuzhu Gao; Jingmin Gu; Yuan Tian; Yaqing Liu; Zheng Jin; Dongmei Yan; Ya-Guang Chen; Xun Zhu
Journal:  Bioinorg Chem Appl       Date:  2016-06-29       Impact factor: 7.778

Review 7.  Recent progress in anti-influenza chemotherapy.

Authors:  S Shigeta
Journal:  Drugs R D       Date:  1999-09

8.  In Vitro Anti-rotaviral Activity of Achillea kellalensis.

Authors:  Reza Taherkhani; Fatemeh Farshadpour; Manoochehr Makvandi
Journal:  Jundishapur J Nat Pharm Prod       Date:  2013-07-17

9.  In vitro Antiviral Activity of Rubia cordifolia Aerial Part Extract against Rotavirus.

Authors:  Yuanyuan Sun; Xuepeng Gong; Jia Y Tan; Lifeng Kang; Dongyan Li; Jihong Yang; Guang Du
Journal:  Front Pharmacol       Date:  2016-09-13       Impact factor: 5.810

10.  Molecular simulation study of the binding mechanism of [α-PTi2W10O40]7- for its promising broad-spectrum inhibitory activity to FluV-A neuraminidase.

Authors:  JianPing Wang; DongHua Hu; ZhongMin Su
Journal:  Chin Sci Bull       Date:  2010-08-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.